Barbara Weber (LinkedIn)

Tan­go Ther­a­peu­tics nabs $60M in CRISPR-based hunt for hid­den can­cer genes

Like a few oth­er CEOs, Bar­bara We­ber emerged from the JP Mor­gan Health­care Con­fer­ence up­beat. She had been test­ing the wa­ters of a Se­ries B …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.